The discrepancy may stem from differential signaling outcomes: the chronic, low-grade elevation of endogenous Musclin during obesity progression may lead to receptor desensitization or compensatory adaptations, allowing its thermogenesis-inhibiting effect to dominate. Here, OSTN is linked to obesity disorder.